Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
2012 · New England Journal of Medicine · 530 citations
https://doi.org/10.1056/nejmoa1111065
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
5.7K
Citations
30
h-index
38
i10-index
Berit Müller is an academic researcher. The author has contributed to research in topics: Metabolomics and Mass Spectrometry Studies & Cancer, Lipids, and Metabolism & Fatty Acid Research and Health. The author has an h-index of 30, co-authored 95 publications.
https://doi.org/10.1056/nejmoa1111065
https://doi.org/10.1186/1471-2407-13-215
https://doi.org/10.1186/bcr2363
https://doi.org/10.1097/pdm.0b013e3181e3630c
https://doi.org/10.1186/1471-2407-9-395
https://doi.org/10.1021/pr200685r
Click to start Chat